ZFP36L1 is regulated by growth factors and cytokines in keratinocytes and influences their VEGF production

References

• Adams S, Pankow S, Werner S, Munz B. 2007. Regulation of NF-κB activity and keratinocyte differentiation by the RIP4 protein: Implications for cutaneous wound repair. J Invest Dermatol. 127:538–544.
   PubMed Web of Science ®Google Scholar
• Amit I, Citri A, Shay T, Lu Y, Katz M, Zhang F, Tarcic G, Siwak D, Lahad J, Jacob-Hirsch J, Amariglio N, Vaisman N, Segal E, Rechavi G, Alon U, Mills GB, Domany E, Yarden Y. 2007. A module of negative feedback regulators defines growth factor signalling. Nat Genet. 39:503–512.
   PubMed Web of Science ®Google Scholar
• Bakheet T, Frevel M, Williams BR, Greer W, Khabar KS. 2001. ARED: Human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res. 29:246–254.
   PubMedGoogle Scholar
• Baou M, Jewell A, Muthurania A, Wickremasinghe RG, Yong KL, Carr R, Marsh P, Murphy JJ. 2009. Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells. Leukemia. 23:986–989.
   Google Scholar
• Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. 2008. Growth factors and cytokines in wound healing. Wound Repair Regen. 16:585–601.
   PubMed Web of Science ®Google Scholar
• Batistatou A, Volonté C, Greene LA. 1992. Nerve growth factor employs multiple pathways to induce primary response genes in PC12 cells. Mol Biol Cell. 3:363–371.
   PubMed Web of Science ®Google Scholar
• Beer HD, Fassler R, Werner S. 2000. Glucocorticoid-regulated gene expression during cutaneous wound repair. Vitam Horm. 59:217–239.
   PubMedGoogle Scholar
• Bell SE, Sanchez MJ, Spasic-Boskovic O, Santalucia T, Gambardella L, Burton GJ, Murphy JJ, Norton JD, Clark AR, Turner M. 2006. The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression. Dev Dyn. 235:3144–3155.
   PubMed Web of Science ®Google Scholar
• Birk DM, Barbato J, Mureebe L, Chaer RA. 2008. Current insights on the biology and clinical aspects of VEGF regulation. Vasc Endovasc Surg. 42:517–530.
   PubMed Web of Science ®Google Scholar
• Blackshear PJ, Phillips RS, Ghosh S, Ramos SB, Richfield EK, Lai WS. 2005. Zfp36l3, a rodent X chromosome gene encoding a placenta-specific member of the Tristetraprolin family of CCCH tandem zinc finger proteins. Biol Reprod. 73:1072.
   Web of Science ®Google Scholar
• Brennan SE, Kuwano Y, Alkharouf N, Blackshear PJ, Gorospe M, Wilson GM. 2009. The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res. 69:5168–5176.
   PubMedGoogle Scholar
• Brook M, Tchen CR, Santalucia T, McIlrath J, Arthur JS, Saklatvala J, Clark AR. 2006. Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. Mol Cell Biol. 26:2408–2418.
   PubMed Web of Science ®Google Scholar
• Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Tognazzi KA, Manseau EJ, Dvorak HF, Van de Water L. 1995. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensivity skin reactions. J Immunol. 154:2801–2807.
   PubMed Web of Science ®Google Scholar
• Busse M, Schwarzburger M, Berger F, Hacker C, Munz B. 2008. TIS11B is a regulator of myogenic differentiation. Eur J Cell Biol. 87:163–172.
   PubMed Web of Science ®Google Scholar
• Cao H, Urban JFJr, Anderson RA. 2008. Insulin increases tristetraprolin and decreases VEGF gene expression in mouse 3T3-L1 adipocytes. Obesity. 16:1208–1218.
   PubMed Web of Science ®Google Scholar
• Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Cerami A. 1986. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA. 83:1670–1674.
   PubMed Web of Science ®Google Scholar
• Carballo E, Lai WS, Blackshear PJ. 1998. Feedback inhibition of macrophage tumor necrosis factor alpha production by tristetraprolin. Science. 281:1001–1005.
   PubMed Web of Science ®Google Scholar
• Carballo E, Lai WS, Blackshear PJ. 2000. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood. 95:1891–1899.
   PubMed Web of Science ®Google Scholar
• Carballo E, Cao H, Lai WS, Kennington EA, Campbell D, Blackshear PJ. 2001. Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway. J Biol Chem. 276:42580–42587.
   PubMed Web of Science ®Google Scholar
• Carrick DM, Blackshear PJ. 2007. Comparative expression of tristetraprolin (TTP) family member transcripts in normal human tissues and cancer cell lines. Arch Biochem Biophys. 462:278–285.
   PubMed Web of Science ®Google Scholar
• Ciais D, Cherradi N, Bailly S, Grenier E, Berra E, Pouyssegur J, Lamarre J, Feige JJ. 2004. Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b. Oncogene. 23:8673–8680.
   PubMed Web of Science ®Google Scholar
• Cooper P, Potter S, Mueck B, Yousefi S, Jarai G. 2001. Identification of genes induced by inflammatory cytokines in airway epithelium. A J Physiol Lung Cell Mol Physiol. 280:841–852.
   PubMed Web of Science ®Google Scholar
• Corps AN, Brown KD. 1995. Insulin and insulin-like growth factor I stimulate expression of the primary response gene cMG1/Tis11b by a wortmannin-sensitive pathway in RIE-1 cells. FEBS Lett. 368:160–164.
   PubMedGoogle Scholar
• Cuenda A, Cohen P, Buée-Scherrer V, Goedert M. 1997. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J. 16:295–305.
   PubMed Web of Science ®Google Scholar
• Dayem MA, Moreilhon C, Turchi L, Magnone V, Christen R, Ponzio G, Barbry P. 2003. Early gene expression in wounded human keratinocytes revealed by DNA microarray analysis. Comp Funct Genomics. 4:47–55.
   PubMed Web of Science ®Google Scholar
• Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, Dvorak HF. 1994. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med. 180:1141–1146.
   PubMed Web of Science ®Google Scholar
• DuBois RN, Bishop PR, Graves-Deal R, Coffey RJ. 1995. Transforming growth factor alpha regulation of two zinc finger-containing immediate early response genes in intestine. Cell Growth Differ. 6:523–529.
   PubMedGoogle Scholar
• Efimova T, Broome AM, Eckert RL. 2003. A regulatory role for p38 delta in keratinocyte differentiation. Evidence for p38 delta-ERK1/2 complex formation. J Biol Chem. 278:34277–34285.
   PubMed Web of Science ®Google Scholar
• Emmons J, Townley-Tilson WH, Deleault KM, Skinner SJ, Gross RH, Whitfield ML, Brooks SA. 2008. Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation. RNA. 14:888–902.
   PubMed Web of Science ®Google Scholar
• Fechir M, Linker K, Pautz A, Hubrich T, Förstermann U, Rodriguez-Pascual F, Kleinert H. 2005. Tristetraprolin regulates the expression of the human inducible nitric-oxide synthase gene. Mol Pharmacol. 67:2148–2161.
   PubMed Web of Science ®Google Scholar
• Fitsialos G, Chassot AA, Turchi L, Dayem MA, LeBrigand K, Moreilhon C, Meneguzzi G, Buscà R, Mari B, Barbry P, Ponzio G. 2007. Transcriptional signature of epidermal keratinocytes subjected to in vitro scratch wounding reveals selective roles for ERK1/2, p38, and phosphatidylinositol 3-kinase signaling pathways. J Biol Chem. 282:15090–15102.
   PubMed Web of Science ®Google Scholar
• Frank S, Hübner G, Breier G, Longaker MT, Greenalgh DG, Werner S. 1995. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem. 270:12607–12613.
   PubMed Web of Science ®Google Scholar
• Frank S, Kämpfer H, Wetzler C, Pfeilschifter J. 2002. Nitric oxide drives skin repair: Novel functions of an established mediator. Kidney Int. 61:882–888.
   PubMed Web of Science ®Google Scholar
• Garcia-Gras EA, Chi P, Thompson EA. 2000. Glucocorticoid-mediated destabilization of cyclin D3 mRNA involves RNA-protein interactions in the 3′-untranslated region of the mRNA. J Biol Chem. 275:22001–22008.
   PubMed Web of Science ®Google Scholar
• Gille J, Reisinger K, Westphal-Varghese B, Kaufmann R. 2001. Decreased mRNA stability as a mechanism of glucocorticoid-mediated inhibition of vascular endocthelial growth factor gene expression by cultured keratinocytes. J Invest Dermatol. 117:1581–1587.
   PubMed Web of Science ®Google Scholar
• Gomperts M, Pascall JC, Brown KD. 1990. The nucleotide sequence of a cDNA encoding an EGF-inducible gene indicates the existence of a new family of mitogen-induced genes. Oncogene. 5:1081–1083.
   PubMed Web of Science ®Google Scholar
• Gomperts M, Corps AN, Pascall JC, Brown KD. 1992. Mitogen-induced expression of the primary response gene cMG1 in a rat intestinal epithelial cell line (RIE-1). FEBS Lett. 306:1–4.
   PubMed Web of Science ®Google Scholar
• Gurtner GC, Werner S, Barrandon Y, Longaker MT. 2008. Wound repair and regeneration. Nature. 453:314–321.
   PubMed Web of Science ®Google Scholar
• Hashimoto K. 2000. Regulation of keratinocyte function by growth factors. J Dermatol Sci. 24:46–50.
   PubMed Web of Science ®Google Scholar
• Horner TJ, Lai WS, Stumpo DJ, Blackshear PJ. 2009. Stimulation of polo-like kinase 3 mRNA decay by tristetraprolin. Mol Cell Biol. 29:1999–2010.
   PubMed Web of Science ®Google Scholar
• Ishmael FT, Fang X, Galdiero MR, Atasoy U, Rigby WF, Gorospe M, Cheadle C, Stellato C. 2008. Role of the RNA-binding protein tristetraprolin in glucocorticoid-mediated gene regulation. J Immunol. 180:8342–8353.
   PubMed Web of Science ®Google Scholar
• Jalonen U, Lahti A, Korhonen R, Kankaanranta H, Moilanen E. 2005. Inhibition of tristetraprolin expression by dexamethasone in activated macrophages. Biochem Pharmacol. 69:733–740.
   PubMed Web of Science ®Google Scholar
• Johnson BA, Geha M, Blackwell TK. 2000. Similar but distinct effects of the tristetraprolin/TIS11 immediate-early proteins on cell survival. Oncogene. 19:1657–1664.
   PubMed Web of Science ®Google Scholar
• Johnson BA, Blackwell TK. 2002. Multiple tristetraprolin sequence domains required to induce apoptosis and modulate responses to TNFalpha through distinct pathways. Oncogene. 21:4237–4246.
   PubMedGoogle Scholar
• Kaneda N, Oshima M, Chung SY, Guroff G. 1992. Sequence of rat TIS11 cDNA, an immediate early gene induced by growth factors and phorbol esters. Gene. 118:289–291.
   PubMed Web of Science ®Google Scholar
• Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, Young PR. 1997. Novel homologues of CSBP/p38 MAP kinase: Activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun. 235:533–538.
   PubMed Web of Science ®Google Scholar
• Lai WS, Stumpo DJ, Blackshear PJ. 1990. Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J Biol Chem. 265:16556–16563.
   PubMed Web of Science ®Google Scholar
• Lai WS, Carballo E, Thorn JM, Kennington EA, Blackshear PJ. 2000. Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to Au-rich elements and destabilization of mRNA. J Biol Chem. 275:17827–17837.
   PubMed Web of Science ®Google Scholar
• Lai WS, Parker JS, Grissom SF, Stumpo DJ, Blackshear PJ. 2006. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol Cell Biol. 26:9196–9208.
   PubMed Web of Science ®Google Scholar
• Ma Q, Herschman HR. 1995. The yeast homologue YTIS11, of the mammalian TIS11 gene family is a non-essential, glucose repressible gene. Oncogene. 10:487–494.
   PubMedGoogle Scholar
• Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR. 2001. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol. 21:6461–6469.
   PubMed Web of Science ®Google Scholar
• Man XY, Yang XH, Cai SQ, Yao YG, Zheng M. 2006. Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Mol Med. 12:127–136.
   PubMed Web of Science ®Google Scholar
• Man XY, Yang XH, Cai SQ, Bu ZY, Zheng M. 2008. Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: Regulated by calcium independent of VEGF. J Cell Mol Med. 12:649–660.
   PubMed Web of Science ®Google Scholar
• Man XY, Yang XH, Cai SQ, Bu ZY, Wu XJ, Lu ZF, Zheng M. 2009. Expression and localization of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in human epidermal appendages: A comparison study by immunofluorescence. Clin Exp Dermatol. 34:396–401.
   PubMed Web of Science ®Google Scholar
• Manabe T, Fukuda K, Pan J, Nagasaki K, Yamaguchi K, Ogawa S. 1999. Hypertrophic stimuli augment expression of cMG1/ERF-1, a putative zinc-finger motif transcription factor, in rat cardiomyocytes. FEBS Lett. 463:39–42.
   PubMed Web of Science ®Google Scholar
• Marderosian M, Sharma A, Funk AP, Vartanian R, Masri J, Jo OD, Gera JF. 2006. Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling. Oncogene. 25:6277–6290.
   PubMed Web of Science ®Google Scholar
• Martin P. 1997. Wound healing–aiming for perfect skin regeneration. Science. 276:75–81.
   PubMed Web of Science ®Google Scholar
• Nakajima K, Wall R. 1991. Interleukin-6 signals activating junB and TIS11 gene transcription in a B-cell hybridoma. Mol Cell Biol. 11:1409–1418.
   PubMed Web of Science ®Google Scholar
• Ogawa K, Chen F, Kim YJ, Chen Y. 2003. Transcriptional regulation of tristetraprolin by transforming growth factor-beta in human T cells. J Biol Chem. 278:30373–30381.
   PubMed Web of Science ®Google Scholar
• Ramos SB, Stumpo DJ, Kennington EA, Phillips RS, Bock CB, Ribeiro-Neto F, Blackshear PJ. 2004. The CCCH tandem zinc-finger protein Zfp36l2 is crucial for female fertility and early embryonic development. Development. 131:4883–4893.
   PubMed Web of Science ®Google Scholar
• Reppe S, Olstad OK, Rian E, Gautvik VT, Gautvik KM, Jemtland R. 2004. Butyrate response factor 1 is regulated by parathyroid hormone and bone morphogenetic protein-2 in osteoblastic cells. Biochem Biophys Res Commun. 324:218–223.
   PubMed Web of Science ®Google Scholar
• Ryle CM, Breitkreutz D, Stark HJ, Leigh IM, Steinert PM, Roop D, Fusenig NE. 1989. Density-dependent modulation of synthesis of keratins 1 and 10 in the human keratinocyte line HACAT and in ras-transfected tumorigenic clones. Differentiation. 40:42–54.
   PubMed Web of Science ®Google Scholar
• Sauer I, Schaljo B, Vogl C, Gattermeier I, Kolbe T, Müller M, Blackshear PJ, Kovarik P. 2006. Interferons limit inflammatory responses by induction of tristetraprolin. Blood. 107:4790–4797.
   PubMed Web of Science ®Google Scholar
• Smoak K, Cidlowski JA. 2006. Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling. Mol Cell Bio. 26:9126–9135.
   PubMed Web of Science ®Google Scholar
• Stoecklin G, Colombi M, Raineri I, Leuenberger S, Mallaun M, Schmidlin M, Gross B, Lu M, Kitamura T, Moroni C. 2003. Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover. EMBO J. 21:4709–4718.
   Web of Science ®Google Scholar
• Stojadinovic O, Lee B, Vouthounis C, Vukelic S, Pastar I, Blumenberg M, Brehm H, Tomic-Canic M. 2007. Novel genomic effects of glucocorticoids in epidermal keratinocytes: Inhibition of apoptosis, interferon-gamma pathway, and wound healing along with promotion of terminal differentiation. J Biol Chem. 282:4021–4034.
   PubMed Web of Science ®Google Scholar
• Stumpo DJ, Byrd NA, Phillips RS, Ghosh S, Maronpot RR, Castranio T, Meyers EN, Mishina Y, Blackshear PJ. 2004. Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the tristetraprolin family. Mol Cell Biol. 24:6445–6455.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Nakajima H, Ikeda K, Maezawa Y, Suto A, Takatori H, Saito Y, Iwamoto I. 2003. IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-alpha production in mast cells. J Exp Med. 198:1717–1727.
   PubMed Web of Science ®Google Scholar
• Taylor GA, Lai WS, Oakey RJ, Seldin MF, Shows TB, Eddy RLJr, Blackshear PJ. 1991. The human TTP protein: Sequence, alignment with related proteins, and chromosomal localization of the mouse and human genes. Nucleic Acids Res. 19:3454.
   PubMed Web of Science ®Google Scholar
• Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, Schenkman DI, Gilkeson GS, Broxmeyer HE, Haynes BF, Blackshear PJ. 1996. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity. 4:445–454.
   PubMed Web of Science ®Google Scholar
• Tchen CR, Brook M, Saklatvala J, Clark AR. 2004. The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself. J Biol Chem. 279:32393–32400.
   PubMed Web of Science ®Google Scholar
• Turchi L, Chassot AA, Rezzonico R, Yeow K, Loubat A, Ferrura B, Lenegrate G, Ortonne JP, Ponzio G. 2002. Dynamic characterization of the molecular events during in vitro epidermal wound healing. J Invest Dematol. 119:56–63.
   PubMed Web of Science ®Google Scholar
• Varnum BC, Lim RW, Sukhatme VP, Herschman HR. Nucleotide sequence of a cDNA encoding TIS11, a message induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate. Oncogene. 1989a; 4:119–120.
   PubMed Web of Science ®Google Scholar
• Varnum BC, Lim RW, Kujubu DA, Luner SJ, Kaufman SE, Greenberger JS, Gasson JC, Herschman HR. Granulocyte-macrophage colony-stimulating factor and tetradecanoyl phorbol acetate induce a distinct, restricted subset of primary response TIS genes in both proliferating and terminally differentiated myeloid cells. Mol Cell Biol. 1989b; 9:3580–3583.
   PubMed Web of Science ®Google Scholar
• Varnum BC, Ma QF, Chi TH, Fletcher B, Herschman HR. 1991. The TIS11 primary response gene is a member of a gene family that encodes proteins with a highly conserved sequence containing an unusual CysHis repeat. Mol Cell Biol. 11:1754–1758.
   PubMed Web of Science ®Google Scholar
• Werner S, Breeden M, Hübner G, Greenhalgh DG, Longaker MT. 1994. Induction of keratinocyte growth factor expression is reduced and delayed in the genetically diabetic mouse. J Invest Dermatol. 103:469–473.
   PubMed Web of Science ®Google Scholar
• Wilgus TA, Matthies AM, Radek KA, Dovi JV, Burns AL, Shankar R, DiPietro LA. 2005. Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am J Pathol. 167:1257–1266.
   PubMed Web of Science ®Google Scholar
• Yang XH, Man XY, Cai SQ, Yao YG, Bu ZY, Zheng M. 2006. Expression of VEGFR-2 on HaCaT cells is regulated by VEGF and plays an active role in mediating VEGF induced effects. Biochem Biophys Res Commun. 349:31–38.
   PubMed Web of Science ®Google Scholar
• Yin T, Yang YC. 1993. Protein tyrosine phosphorylation and activation of primary response genes by interleukin 11 in B9-TY1 cells. Cell Growth Differ. 4:603–609.
   PubMedGoogle Scholar
• Yoo PS, Mulkeen AL, Cha CH. 2006. Post-transcriptional regulation of vascular endothelial growth factor: Implications for tumor angiogenesis. World J Gastroenterol. 12:4937–4942.
   PubMed Web of Science ®Google Scholar